Current evidence suggests dulaglutide (Trulicity) and extended-release exenatide (Bydureon) generally demonstrate lower nausea rates (approximately 8-12% at lower doses) compared to twice-daily exenatide or higher-dose semaglutide and liraglutide used for weight management
[DOI] [Google Scholar] 239.Slingu M
Once appetite returns, staying consistent with protein, portions, and balanced meals gets a lot harder than it was on the medication
The starting dose of retatrutide guide and the retatrutide dosage chart detail the recommended approach
This dynamic process helps regulate blood sugar levels, keeping them within a healthy range
In the future, patients using GLP-1 patches with GLP-1 or GIP/GLP-1 molecules may experience the side effects of GLP-1 agonist drugs, such as constipation, diarrhea, vomiting, abdominal pain, gallbladder disease, pancreatitis, kidney injury, and hypoglycemia